Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 6 | 160247357 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 5 | 2016 | 2019 | |||||||||
|
1.000 | 0.080 | 6 | 160247357 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 4 | 2010 | 2019 | |||||||||
|
1.000 | 0.080 | 6 | 160247357 | intron variant | A/G;T | snv |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 2 | 2010 | 2012 | ||||||||
|
6 | 160254732 | intron variant | T/C;G | snv |
|
0.700 | 1.000 | 2 | 2016 | 2016 | |||||||||||
|
6 | 160248049 | intron variant | A/G | snv | 0.89 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | ||||||||||
|
1.000 | 0.080 | 6 | 160212075 | intron variant | T/A;G | snv | 0.12 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 6 | 160212075 | intron variant | T/A;G | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
6 | 160210138 | intron variant | G/T | snv | 1.4E-02 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
1.000 | 0.040 | 6 | 160236104 | intron variant | GTT/- | delins | 9.8E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.040 | 6 | 160236104 | intron variant | GTT/- | delins | 9.8E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 6 | 160236104 | intron variant | GTT/- | delins | 9.8E-02 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
6 | 160204267 | intron variant | C/T | snv | 6.5E-03 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
1.000 | 0.080 | 6 | 160247357 | intron variant | A/G;T | snv |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
6 | 160240136 | intron variant | T/G | snv | 9.8E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
6 | 160260361 | 5 prime UTR variant | A/G | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||||
|
6 | 160260361 | 5 prime UTR variant | A/G | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||||
|
6 | 160254732 | intron variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
6 | 160248049 | intron variant | A/G | snv | 0.89 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
6 | 160265636 | intron variant | T/C | snv | 0.89 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
6 | 160227235 | intron variant | T/G | snv | 0.72 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.790 | 0.360 | 6 | 160249250 | missense variant | A/C | snv | 0.90 | 0.89 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||||
|
1.000 | 0.080 | 6 | 160250619 | missense variant | G/A | snv | 3.4E-04 | 9.8E-05 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.790 | 0.360 | 6 | 160249250 | missense variant | A/C | snv | 0.90 | 0.89 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
|
0.790 | 0.360 | 6 | 160249250 | missense variant | A/C | snv | 0.90 | 0.89 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.790 | 0.360 | 6 | 160249250 | missense variant | A/C | snv | 0.90 | 0.89 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 |